Literature DB >> 15054368

Outcomes after nasal septoplasty: results from the Nasal Obstruction Septoplasty Effectiveness (NOSE) study.

Michael G Stewart1, Timothy L Smith, Edward M Weaver, David L Witsell, Bevan Yueh, Maureen T Hannley, Jonas T Johnson.   

Abstract

OBJECTIVE: Our goal was to assess disease-specific quality of life outcomes after nasal septoplasty in adults with nasal obstruction. DESIGN, SETTINGS, AND PATIENTS: We conducted a prospective observational outcomes multicenter study with 14 sites and 16 investigators, including private practice and academic settings. Patients had had septal deviation and symptomatic nasal obstruction for at least 3 months, and medical management had failed.
METHODS: Patients with septal deviation completed a validated outcomes instrument (the Nasal Obstruction Septoplasty Effectiveness [NOSE] scale) before and 3 and 6 months after septoplasty, with or without partial turbinectomy.
RESULTS: Fifty-nine patients underwent surgery; there was a significant improvement in mean NOSE score at 3 months after septoplasty (67.5 versus 23.1, P < 0.0001), and this improvement was unchanged at 6 months. Patient satisfaction was very high, and patients used significantly fewer nasal medications.
CONCLUSIONS: In patients with septal deformity, nasal septoplasty results in significant improvement in disease-specific quality of life, high patient satisfaction, and decreased medication use.

Entities:  

Mesh:

Year:  2004        PMID: 15054368     DOI: 10.1016/j.otohns.2003.12.004

Source DB:  PubMed          Journal:  Otolaryngol Head Neck Surg        ISSN: 0194-5998            Impact factor:   3.497


  85 in total

1.  Does septoplasty enhance the quality of life in patients?

Authors:  Maija L Hytönen; Markus Lilja; Antti A Mäkitie; Harri Sintonen; Risto P Roine
Journal:  Eur Arch Otorhinolaryngol       Date:  2012-01-25       Impact factor: 2.503

2.  Computed nasal resistance compared with patient-reported symptoms in surgically treated nasal airway passages: a preliminary report.

Authors:  Julia S Kimbell; Guilherme J M Garcia; Dennis O Frank; Daniel E Cannon; Sachin S Pawar; John S Rhee
Journal:  Am J Rhinol Allergy       Date:  2012 May-Jun       Impact factor: 2.467

3.  Estimates of nasal airflow at the nasal cycle mid-point improve the correlation between objective and subjective measures of nasal patency.

Authors:  Courtney Gaberino; John S Rhee; Guilherme J M Garcia
Journal:  Respir Physiol Neurobiol       Date:  2017-01-09       Impact factor: 1.931

4.  Studying Life Effects & Effectiveness of Palatopharyngoplasty (SLEEP) study: subjective outcomes of isolated uvulopalatopharyngoplasty.

Authors:  Edward M Weaver; B Tucker Woodson; Bevan Yueh; Timothy Smith; Michael G Stewart; Maureen Hannley; Kristine Schulz; Milesh M Patel; David Witsell
Journal:  Otolaryngol Head Neck Surg       Date:  2011-02-10       Impact factor: 3.497

5.  Normative ranges of nasal airflow variables in healthy adults.

Authors:  Azadeh A T Borojeni; Guilherme J M Garcia; Masoud Gh Moghaddam; Dennis O Frank-Ito; Julia S Kimbell; Purushottam W Laud; Lisa J Koenig; John S Rhee
Journal:  Int J Comput Assist Radiol Surg       Date:  2019-07-02       Impact factor: 2.924

Review 6.  Perennial rhinitis.

Authors:  Hesham A Saleh; Stephen R Durham
Journal:  BMJ       Date:  2007-09-08

7.  Severe deviated nose treatment: importance of preserving the dorsal septal remnant.

Authors:  Amir A Sazgar; Yeganeh Teimouri; Sara Arjang; Amin Amali; Sam P Most
Journal:  Eur Arch Otorhinolaryngol       Date:  2019-02-02       Impact factor: 2.503

8.  Endoscopic versus conventional septoplasty: objective/subjective data on 276 patients.

Authors:  Massimiliano Garzaro; Valeria Dell'Era; Giuseppe Riva; Luca Raimondo; Giancarlo Pecorari; Paolo Aluffi Valletti
Journal:  Eur Arch Otorhinolaryngol       Date:  2019-03-20       Impact factor: 2.503

Review 9.  A systematic review of patient-reported outcome measures after rhinoplasty.

Authors:  M Barone; A Cogliandro; N Di Stefano; V Tambone; P Persichetti
Journal:  Eur Arch Otorhinolaryngol       Date:  2016-10-31       Impact factor: 2.503

10.  Treatment of congestion in upper respiratory diseases.

Authors:  Eli O Meltzer; Fernan Caballero; Leonard M Fromer; John H Krouse; Glenis Scadding
Journal:  Int J Gen Med       Date:  2010-04-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.